McLean, VA, August 4, 2015, ZH HealthcareTM (ZHTM), the creators of blueEHRTM, a Health IT as a ServiceTM (HITaaSTM) platform that is customizable and flexible with a set of tools and modules that can be configured or assembled by healthcare providers and entrepreneurs in little time and effort, announced today that Sid Pandit joins the ZHTM Advisory Board.
Shameem C. Hameed, Chairman and CEO of ZHTM, stated that, “Mr. Pandit’s legal experience and perspectives especially with regard to IP will be invaluable for ZHTM as it further delivers its innovative platform solution for healthcare technology. We sincerely appreciate his time and are excited to have to Mr. Pandit as part of the ZHTM Advisory Board,” said Hameed.
Mr. Pandit is a Partner in the Intellectual Property Litigation Practice of Smith, Gambrell, & Russell, LLP, in Washington, D.C. Mr. Pandit’s practice focuses on patent litigation and patent prosecution. He represents clients across a wide range of industries in patent litigations around the U.S., including the Eastern District of Texas, the Eastern District of Virginia, and the District of Delaware.
“ZH Healthcare’s innovative health technology platform has significant potential to scale globally. The shared goal of the Advisory Board is to help the team realize that potential,” said Mr. Pandit.